Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
USD | Fiscal Year Ending | | Latest |
(in millions) | Dec-14 | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | Dec-22 | Dec-23 | | Jun-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 51 | 89 | 104 | 138 | 94 | 80 | 55 | 58 | 71 | 50 | | 44 |
% Growth | NA | 75.9% | 16.1% | 32.8% | -32.1% | -14.8% | -31.2% | 5.3% | 22.8% | -29.0% | | |
| | | | | | | | | | | | |
Cost of Revenue | (23) | (48) | (50) | (64) | (30) | (26) | (36) | (30) | (30) | (23) | | (20) |
Gross Profit | 28 | 41 | 53 | 73 | 63 | 54 | 19 | 27 | 41 | 27 | | 24 |
% Revenue | 54.4% | 46.0% | 51.5% | 53.1% | 67.8% | 67.4% | 33.9% | 47.5% | 57.6% | 54.5% | | 53.7% |
| | | | | | | | | | | | |
Research and Development | (1) | (1) | (2) | (4) | (1) | (2) | (3) | (4) | (5) | (3) | | (3) |
Selling and Marketing | (2) | (3) | (4) | (6) | (5) | (5) | (10) | (12) | (23) | (19) | | (17) |
General and Admin | (10) | (14) | (17) | (22) | (20) | (21) | 0 | 0 | 0 | 0 | | 0 |
Other Inc / (Exp) | (1) | (3) | (0) | (0) | (0) | (83) | (5) | (10) | (7) | (51) | | (56) |
Total Operating Exp | (14) | (21) | (23) | (32) | (27) | (110) | (17) | (26) | (35) | (72) | | (76) |
| | | | | | | | | | | | |
Operating Income | 13 | 20 | 30 | 41 | 37 | (57) | 1 | 2 | 5 | (45) | | (52) |
% Revenue | 26.3% | 22.8% | 29.0% | 29.6% | 39.2% | -71.1% | 2.3% | 3.0% | 7.7% | -88.7% | | -119.5% |
| | | | | | | | | | | | |
Interest Expense | (0) | 4 | 1 | (1) | (1) | (1) | (0) | (1) | (0) | (0) | | 1 |
Pre-tax Income | 13 | 24 | 31 | 39 | 36 | (58) | 1 | 1 | 5 | (45) | | (51) |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | (11) | 2 | 0 | 3 | (13) | (2) | | (8) |
Provision for Taxes | (1) | (4) | (5) | (7) | (4) | (3) | (0) | 2 | (2) | (1) | | (0) |
Net Income to Company | 12 | 20 | 26 | 32 | 21 | (59) | 1 | 6 | (9) | (47) | | (60) |
% Margin | 23.5% | 22.6% | 24.7% | 23.2% | 22.2% | -73.7% | 1.4% | 9.8% | -13.3% | -93.5% | | -137.9% |
| | | | | | | | | | | | |
Minority Interest in Earnings | (2) | (1) | (2) | (2) | (1) | (1) | (0) | 0 | 0 | 0 | | 0 |
Net Income to Stockholders | 10 | 19 | 24 | 30 | 20 | (59) | 1 | 6 | (9) | (47) | | (60) |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 11 | (2) | 0 | (3) | 13 | 2 | | 8 |
| | | | | | | | | | | | |
Net Income to Common | 10 | 19 | 24 | 30 | 31 | (62) | 1 | 3 | 3 | (46) | | (52) |
% Margin | 19.4% | 21.0% | 23.1% | 22.0% | 33.3% | -77.4% | 1.0% | 4.9% | 4.8% | -90.4% | | -118.6% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 0.06 | 0.10 | 0.12 | 0.15 | 0.14 | (0.31) | 0.00 | 0.01 | 0.01 | (0.17) | | (0.20) |
Diluted EPS (Continuing Ops) | 0.05 | 0.10 | 0.12 | 0.15 | 0.14 | (0.31) | 0.00 | 0.01 | 0.01 | (0.17) | | (0.20) |
| | | | | | | | | | | | |
WA Basic Shares Out. | 174.40 | 191.98 | 195.13 | 198.74 | 215.44 | 198.40 | 184.27 | 245.71 | 262.59 | 262.59 | | 259.49 |
WA Diluted Shares Out. | 178.80 | 195.92 | 198.84 | 202.33 | 217.33 | 198.40 | 184.37 | 246.37 | 262.59 | 262.59 | | 259.49 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 13 | 24 | 31 | 39 | 36 | (58) | 1 | 1 | 5 | (45) | | (51) |
Addback: Net Interest Expense | 0 | (4) | (1) | 1 | 1 | 1 | 0 | 1 | 0 | 0 | | (1) |
Addback: Other Non Operating Expenses, Total | 1 | 3 | 0 | 0 | 0 | 0 | (1) | (1) | 1 | (0) | | 2 |
Addback: Depreciation & Amortization | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | | (0) |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 5 | 4 | 3 | | 3 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 24 | 0 | 0 | 0 | 2 | | 2 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 1 |
Addback: Asset Writedown | 0 | 0 | 0 | 0 | 0 | 58 | 1 | 0 | 0 | 43 | | 43 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 3 |
Adjusted EBITDA | 15 | 24 | 31 | 42 | 38 | 27 | 2 | 9 | 11 | 3 | | 0 |
% Margin | 30.3% | 26.8% | 30.1% | 30.4% | 40.8% | 34.2% | 3.8% | 15.3% | 15.6% | 5.2% | | 1.0% |
| | | | | | | | | | | | |
Adjusted EBIT | 15 | 23 | 30 | 41 | 37 | 26 | 1 | 8 | 11 | 2 | | 1 |
% Margin | 28.8% | 25.7% | 29.0% | 29.6% | 39.6% | 33.1% | 2.0% | 14.3% | 15.2% | 4.6% | | 1.5% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 12 | 20 | 26 | 32 | 21 | (59) | 1 | 6 | (9) | (47) | | (60) |
Addback: Unusual Items | 0 | 0 | 0 | 0 | 0 | 83 | 1 | 7 | 5 | 47 | | 51 |
Less: Tax Benefit of Unusual Items (26%) | 0 | 0 | 0 | 0 | (0) | (22) | (0) | (2) | (1) | (12) | | (13) |
Adjusted Net Income | 12 | 20 | 26 | 32 | 21 | 3 | 1 | 11 | (6) | (12) | | (23) |
% Margin | 23.5% | 22.6% | 24.7% | 23.2% | 22.5% | 3.4% | 2.7% | 18.9% | -8.5% | -23.7% | | -52.2% |